AULT MILTON C III 13D and 13G filings for Alzamend Neuro, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-02-02 4:38 pm Purchase |
2024-01-31 | 13D | Alzamend Neuro, Inc. ALZN |
AULT MILTON C III | 315,804 40.300% |
122,000![]() (+62.95%) |
Filing |
2024-01-25 5:21 pm Purchase |
2024-01-23 | 13D | Alzamend Neuro, Inc. ALZN |
AULT MILTON C III | 193,804 29.400% |
193,804![]() (New Position) |
Filing |